Overview
Status
Active
Registry date
2014-10-29
Share capital
5,000.00 PLN
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2021 – the filing deadline has passed.
- 2021not filed
- 202013/09/2021
- 201914/10/2020
- 201821/06/2019
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2020.
Results vs industry
Revenue
This companyUSD 53.91kMedianUSD 55.24kAverageUSD 2.71m
Net profit
This companyUSD -7.07kMedianUSD -1.27kAverageUSD -91.85k
Operating costs
This companyUSD 59.99kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 27.88kMedianUSD 133.19kAverageUSD 3.03m
Industry
Authorized Representatives
Paulina Grudzińska – President of the Management Board
Manner of representation
Each member of the management board is authorised to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Joanna Ciomborowska Basheerage 43 | 7 | $189.09 | 14% |
Izabela Alina Makałowskaage 63 | 9 | $243.11 | 18% |
Dariusz Stankiewiczage 47 | 26 | $702.32 | 52% |
Michał Szcześniakage 41 | 8 | $216.10 | 16% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2015-04-17 to 2024-10-21.
Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)
Debt
9 closed proceedings recorded in KRZ history.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Aug 26, 2025 | Discontinued enforcement proceedings | Closed | |
| Aug 26, 2025 | Discontinued enforcement proceedings | Closed | |
| Aug 26, 2025 | Discontinued enforcement proceedings | Closed | |
| Aug 26, 2025 | Discontinued enforcement proceedings | Closed | |
| Aug 26, 2025 | Discontinued enforcement proceedings | Closed |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jun 17, 2026 | Dissolution without liquidation opened | |
| Mar 28, 2025 | Dissolution without liquidation opened |
Public aid
9 public aid cases recorded, with a total value of $997,636.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 13, 2021 | Aid for research and development projects: industrial research | $949.2K$949,192 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Oct 13, 2021 | Aid for research and development projects: experimental development | $38,439$38,439 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $189$189 | Prezes Zakładu Ubezpieczeń Społecznych |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-09-01 | Development of a high-throughput system enabling rapid assessment of the biological activity of compounds targeting the SARS-CoV-2 replication complex, identification of compounds with the highest therapeutic potential, and assessment of their cytotoxicity to human cells | $987.6K$987,631 | Operational Programme Smart Growth |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| GenxoneS.A. | $665,361.35 | genxone.eu | ||
| Polbiotech Laboratoriumsp. z o.o. | $645,943.81 | polbiotech.pl | ||
| Relvosp. z o.o. | $120,693.26 | relvo.pl | ||
| Microblicsp. z o.o. | $122,383.50 | microblic.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| GenomtecS.A. | $54,746.36 | genomtec.com | ||
| Przedsiębiorstwo Wielobranżowe Genezasp. z o.o. | $54,163.54 | geneza.eu | ||
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com | ||
| MIMO BiotechP.S.A. | – | mimobiotech.com |
Change history
| Date | Event | |
|---|---|---|
| 2024-11-21 | Address change (Ul. Święty Marcin 29/8, 61-806, Poznań → Poznań) | |
| 2024-02-13 | Address change (Ul. Rubież 46/C4, 61-612, Poznań → Ul. Święty Marcin 29/8, 61-806, Poznań) | |
| 2021-05-28 | Address change (Ul. Rubież 46/C4, 61-761, Poznań → Ul. Rubież 46/C4, 61-612, Poznań) | |
| 2020-12-29 | Address change (Wichrowe Wzgórze 2/12, 61-672, Poznań → Ul. Rubież 46/C4, 61-761, Poznań) | |
| 2017-06-28 | PKD change (Removed: 58.14.Z, 58.19.Z) |
FAQ
The main business activity of Ideas4biology focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on October 29, 2014.
The headquarters is located at: Poznań.
The management board consists of: Paulina Grudzińska (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2020 to December 31, 2020.
The company reported a revenue of $53,907 in 2020, which is a decrease of 20.1% compared to 2019.
No, in 2020 the company was not profitable, reporting a net loss of $7,070.
The largest operating cost category falls under employee remuneration. This category amounted to $40,758 in 2020, representing 68% of all operating expenses.
Last updated: 2026-04-09